Autisme: la prévalence de ces troubles a augmenté de 78% entre 2007 et 2012

Autisme aux Etats-Unis : un sur quatre-vingt-huit

Autisme aux Etats-Unis : un sur quatre-vingt-huit
Stéphane Foucart est journaliste scientifique au Monde

Au niveau de 2012, c’est un garçon sur 54 qui est touché par l’autisme, contre une fille sur 252.

Cette susceptibilité variable en fonction du sexe met immanquablement sur la piste des perturbateurs endocriniens, ces molécules de synthèse omniprésentes, qui interfèrent avec le système hormonal et produisent le gros de leurs effets au cours de la période fœtale

Bien sûr, il n’y a pas de consensus scientifique sur ce lien possible avec l’autisme, mais un simple soupçon, fût-il étayé.

Lisez Autisme aux Etats-Unis : un sur quatre-vingt-huit
Stéphane Foucart, LeMonde, 21 Oct 2013.

Plus sur le BPA – Hhorages – pesticides – perturbateurs endocriniens
Un tout grand merci à Michel Detry pour son tweet informatif  :-)

My Mother was given DiEthylStilbestrol DES during her Pregnancy and my Story begins

Starting a Family as a DES Daughter… on Hormones Matter

She Was Given DES and My Story Begins
Personal Stories

My story is not special other than it is my story. My mother, a Navy wife, got pregnant with her first child on her honeymoon. Nine months later a healthy baby girl was born. Over the next six years she suffered miscarriage after miscarriage in an attempt to expand her family. Finally, late in 1954 she learned that she was once again pregnant. The doctors told her that there was a wonderful medication available to help support the pregnancy. She was given diethylstilbestrol (DES) and my story begins… ”

Continue reading She Was Given DES and My Story Begins
Hormones Matter, 24 Sept 2013

More DES DiEthylStilbestrol Resources

Pharma medical specialists sitting on advisory boards, listing, marketing their drugs

Directions: Advise, Get Paid, Keep Quiet

Directions: Advise, Get Paid, Keep Quiet
Big Pharma pays big bucks for medical specialists to sit on advisory boards, guiding the listing and marketing of their drugs. Now we know how much money – but not which doctors – are getting paid.

Advisory boards are groups of medical professionals hired to meet and consult with a pharmaceutical company about its product. The medicos might advise on how to get the drug through regulation hoops, on the appropriateness of marketing materials, or how the drug can be dispensed for greatest reach.

As with the fictional fight club, these meetings are secret; doctors involved sign confidentiality agreements and very rarely do companies disclose who their adviser-doctors are. Now we know how much money – but not which doctors – are getting paid.

Read Directions: Advise, Get Paid, Keep Quiet
by Clare Blumer, Digital Global Mail Ltd, 27 Aug 2013

Fighting Cancer with alternative Therapies

Four Women and their Natural Therapies Experiences

“I feel empowered, in control of my body”

'I feel empowered, in control of my body': four women on fighting cancer with alternative therapies
Breaking news, analysis and more from The Daily and Sunday Telegraph

There is a growing number of people in Britain seeking alternative approaches to cancer treatment, and making their voices heard.

Four women who have embraced natural therapies in their fight against cancer talk to Anna Moore about their experiences.

Read I feel empowered, in control of my body,
The Telegraph, 20 October 2013.

Have you heard “The Journey of a DES Daughter”?

Your @DES_Journal Interview by @TheOrganicView is on @SoundCloud

Recorded radio interview by The Organic View, with host, June Stoyer joined by your DES Daughter Domino talking about her journey.

Related posts

More DES DiEthylStilbestrol Resources

Deadly Medicines and Organised Crime

How Big Pharma has Corrupted Healthcare

How big pharma has corrupted healthcare by Peter Gøtzsche on Flickr
Peter Gøtzsche’s book tells us “drug companies don’t sell drugs, they sell lies about drugs…”

From the introduction:

The main reason we take so many drugs is that drug companies don’t sell drugs, they sell lies about drugs. This is what makes drugs so different from anything else in life…Virtually everything we know about drugs is what the companies have chosen to tell us and our doctors… the reason patients trust their medicine is that they extrapolate the trust they have in their doctors into the medicines they prescribe. The patients don’t realise that, although their doctors may know a lot about diseases and human physiology and psychology, they know very, very little about drugs that hasn’t been carefully concocted and dressed up by the drug industry…If you don’t think the system is out of control, then please email me and explain why drugs are the third leading cause of death… If such a hugely lethal epidemic had been caused by a new bacterium or a virus, or even one hundredth of it, we would have done everything we could to get it under control. ”

The book Deadly Medicines and organised Crime, by Peter Gøtzsche, addresses in great evidence-based detail, a general system failure caused by widespread crime, corruption, bribery and impotent drug regulation in need of radical reforms.

Concerns about Endocrine Disruptor Bisphenol-A and Breast Cancer

USA TODAY health reporter Liz Szabo explains the concerns regarding BPA and breast cancer

Researchers raise concerns about BPA and breast cancer
Liz Szabo, USA TODAY medical reporter covering cancer, heart disease, pediatrics, public health, women’s health, kids/parenting, AIDS, some environmental health

A growing number of health advocates are raising concerns about possible links between the estrogen-like chemical Bisphenol-A (BPA) and breast cancer.

Consumer concern about bisphenol A, has led manufacturers to remove it from baby bottles and infant formula packaging.

Still, BPA also could pose a risk to children long before they take their first sip of milk, according to a September report from the Breast Cancer Fund advocacy group.
Babies also are exposed in the womb, the report finds.

Read Researchers raise concerns about BPA and breast cancer
Liz Szabo, USA TODAY, 5 Oct 2013

More about BPA and Endocrine Disruptors – Breast Cancer

Pregnancies from Donor Eggs: Trends, Outcomes of/for Donor Oocyte Cycles in Assisted Reproduction

Studies of donor oocytes and the risk of adverse perinatal outcomes have provided inconsistent results

Trends, Outcomes of/for Donor Oocyte Cycles in Assisted Reproduction
The Journal of the American Medical Association, published since 1883, is an international peer-reviewed general medical journal published 48 times per year

The probability of a pregnancy resulting in a healthy live birth decreases as women age, particularly after age 35 years. The likelihood of a spontaneous conception decreases, whereas the risks of miscarriage and a range of late obstetric and perinatal complications increase. Assisted reproductive technology (ART) has allowed many couples who would otherwise be unable to have children to have successful pregnancies, but the age-related biological barriers to establishing an ongoing pregnancy that result from increasing maternal age have been difficult to overcome, even with transfer of multiple embryos. However, although multiple-embryo transfer increases the chances of pregnancy, it also increases the likelihood of adverse pregnancy outcomes, particularly those related to preterm delivery. In addition, ART is associated with an increased risk of adverse obstetric and perinatal outcomes compared with spontaneous conception, even with singleton pregnancies, although the relative contribution of ART vs the underlying cause of infertility to these outcomes is unclear. For couples unable to achieve a successful pregnancy through ART with autologous oocytes, presumably because of idiopathic or age-related declines in ovarian reserve, the use of donor oocytes provides an alternative to replacement of multiple embryos derived from autologous oocytes (or an additional option after unsuccessful cycles with multiple embryos). Although the use of donor oocytes increases the probability of conception and live birth in older women,7 studies of donor oocytes and the risk of adverse perinatal outcomes have provided inconsistent results.

Sources and FULL article: Outcomes of Donor Oocyte Cycles in Assisted Reproduction, JAMA, 17 Oct 2013

The prevalence of oocyte donation for in vitro fertilization (IVF) has increased in the United States – from +- 8,000 cycle attempts using donor eggs in 2000 to +/- 18,000 cycle attempts using donor eggs in 2010 – but little information is available regarding maternal or infant outcomes to improve counseling and clinical decision making.

Sources and FULL article: Trends and Outcomes for Donor Oocyte Cycles in the United States, 2000-2010, JAMA, 17 Oct 2013.

More about Fertility – IVF – Pregnancy – Surrogacy

Sadly for many DES daughters having their own children is not possible! Many of us who have experienced miscarriages, want to have kids but are struggling or unable to…
More about DES pregnancy risks – Read DES studies on fertility and pregnancy.

Most Americans think Miscarriage is rare, caused by Stressful Experiences

Miscarriage Perceptions vs. Reality: Public Understanding Not in Sync with Facts

Miscarriage Perceptions vs. Reality: Public Understanding Not in Sync with Facts
Albert Einstein College of Medicine. Biomedical research, medical education and clinical advances

The majority of Americans are misinformed about the causes and frequency of miscarriages, a national survey shows.

Most of those surveyed said they thought miscarriage was rare, and believed that stressful events or chronic stress were the major causes. These false beliefs often lead to feelings of guilt or blame in parents who experience a miscarriage, according to the researchers.

Read Miscarriage Perceptions vs. Reality: Public Understanding Not in Sync with Facts
Albert Einstein College of Medicine, 16 Oct 2013

DES daughters have a higher risk of recurrent miscarriages.
If you know or think you may have been exposed to DES it’s important to inform your doctor and gynaecologist.

Related posts:

Preventieve screening DES-dochters

Protocol gynaecologisch onderzoek 2012, DES Centrum

Preventieve screening DES-dochters:  Protocol gynaecologisch  onderzoek 2012
Hier kunt u @DESCentrum tekst lezen, downloaden en eventueel printen

Het screeningsprotocol dat in onderstaand artikel beschreven staat is in 2012 geëvalueerd en opnieuw geformuleerd.

Beste huisartsen en gynaecologen, hier vindt u het DES-sceeningsprotocol voor DES-dochters.

Bedankt DES Centrum voor de DES ScreeningsProtocol!

More DES DiEthylStilbestrol Resources